Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.
Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.
复制标题
DOI:
10.1073/pnas.2108957118
复制
发表时间:
2021-10-26
影响因子:
11.1
通讯作者:
Weiss A
中科院分区:
文献类型:
--
作者:
Lu W;Skrzypczynska KM;Weiss A
B lymphocytes recognize pathogenic antigens and become activated via their B cell receptors (BCR). This BCR-dependent activation is controlled by Src-family kinases (SFKs). It is unclear how B cells tolerate the fluctuations of SFK activities and maintain unresponsiveness in the absence of foreign antigens. Using a chemical-genetic system, we acutely inhibited C-terminal Src kinase to enhance the SFK activity in mouse B cells. Surprisingly, we observed marked inhibition of BCR-downstream signaling due to associated impairment of the phosphatidylinositol-trisphosphate pathway. These results reveal the critical importance of maintaining a proper amount of SFK activity in quiescent B cells for appropriate BCR-dependent responses, which may be critical for naïve B cell unresponsiveness to self-antigens to maintain peripheral tolerance. T cell antigen receptor (TCR) and B cell antigen receptor (BCR) signaling are initiated and tightly regulated by Src-family kinases (SFKs). SFKs positively regulate TCR signaling in naïve T cells but have both positive and negative regulatory roles in BCR signaling in naïve B cells. The proper regulation of their activities depends on the opposing actions of receptor tyrosine phosphatases CD45 and CD148 and the cytoplasmic tyrosine kinase C-terminal Src kinase Csk. Csk is a major negative regulator of SFKs. Using a PP1-analog-sensitive Csk (CskAS) system, we have previously shown that inhibition of CskAS increases SFK activity, leading to augmentation of responses to weak TCR stimuli in T cells. However, the effects of Csk inhibition in B cells were not known. In this study, we surprisingly found that inhibition of CskAS led to marked inhibition of BCR-stimulated cytoplasmic free calcium increase and Erk activation despite increased SFK activation in B cells, contrasting the effects observed in T cells. Further investigation revealed that acute CskAS inhibition suppressed BCR-mediated phosphatidylinositol 3,4,5-trisphosphate (PIP3) production in B cells. Restoring PIP3 levels in B cells by CD19 cross-linking or SHIP1 deficiency eliminated the negative regulatory effect of CskAS inhibition. This reveals the critical role of Csk in maintaining an appropriate level of SFK activity and regulating PIP3 amounts as a means of compensating for SFK fluctuations to prevent inappropriate B cell activation. This regulatory mechanism controlling PIP3 amounts may also contribute to B cell anergy and self-tolerance.
登录
查看更多内容
DOI:
10.1084/jem.20020515
发表时间:
2002-12-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hibbs ML;Harder KW;Armes J;Kountouri N;Quilici C;Casagranda F;Dunn AR;Tarlinton DM
通讯作者:
Tarlinton DM
影响因子:
7.3
作者:
Mukherjee S;Zhu J;Zikherman J;Parameswaran R;Kadlecek TA;Wang Q;Au-Yeung B;Ploegh H;Kuriyan J;Das J;Weiss A
通讯作者:
Weiss A
影响因子:
30.5
作者:
Chang VT;Fernandes RA;Ganzinger KA;Lee SF;Siebold C;McColl J;Jönsson P;Palayret M;Harlos K;Coles CH;Jones EY;Lui Y;Huang E;Gilbert RJC;Klenerman D;Aricescu AR;Davis SJ
通讯作者:
Davis SJ
影响因子:
20.3
作者:
Cordoba, Shaun-Paul;Choudhuri, Kaushik;van der Merwe, P. Anton
通讯作者:
van der Merwe, P. Anton
影响因子:
5.3
作者:
Dobenecker, MW;Schmedt, C;Tarakhovsky, A
通讯作者:
Tarakhovsky, A